An artificial joint is a device used in orthopedic surgery procedures in which an arthritic or dysfunctional joint surface is surgically replaced. They are also called prostheses and designed to enable improved joint function and correct abnormalities associated with joint movement. Artificial joints can be prepared from alloy, metal, ceramic, or oxinum and implanted into the site depending on the patient, surgeon, and feasibility of the procedure.
Strategic insights for the North America Artificial Joints provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 7,234.2 Million |
Market Size by 2027 | US$ 11,440.2 Million |
Global CAGR (2019 - 2027) | 6.0% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The geographic scope of the North America Artificial Joints refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The North America Artificial Joints market was valued at US$ 7,234.2 million in 2019 and is projected to reach US$ 11,440.2 million by 2027; it is expected to grow at a CAGR of 6.0% during the forecast period. North America Artificial Joints market is expected to grow due to factors such as to increasing prevalence of bone and joint disorders, increasing prevalence of obesity, and rising government support by introducing guidelines for regenerative medicines. However, high cost and complications associated with the artificial joint surgery is expected to hinder market growth.
Based on Product, the North America Artificial Joints market is segmented into cemented joints and non-cemented joints. The cemented joints segment held the largest share of the market in 2019 and is expected to register the highest CAGR in the market during the forecast period.
The North America Artificial Joints market, by material, is segmented into ceramics, alloys, oxinium, others. The ceramic segment held the largest share of the market in 2019, however, alloys segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on Application, the North America Artificial Joints market is segmented into artificial joints of knee, artificial joints of hip, artificial joints of shoulder, others. The artificial joints of knee segment held the largest share of the market in 2019 and is expected to register the highest CAGR in the market during the forecast period.
The North America Artificial Joints market, based on end user, is segmented into artificial joints of hospitals, ambulatory care centers, and other end users. The hospital segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period.
Some of the major primary and secondary sources associated with this report on the North America Artificial Joints market are the US Food and Drug Administration (FDA), International Society of Arthroplasty, Knee Surgery and Orthopedic Sports Medicine (ISAKOS), World Health Organization (WHO) and National Health Service (NHS).
• Cemented Joints
• Non-Cemented Joints
• Ceramics
• Alloys
• Oxinium
• Others
• Artificial Joints of Knee
• Artificial Joints of Hip
• Artificial Joints of Shoulder
• Others
• Hospital
• Ambulatory Care Centers
• Others
• United States
• Canada
• Mexico
• Smith & Nephew
• Stryker Corporation
• Zimmer Biomet
• Medtronic
• Braun Melsungen AG
• Colfax Corporation
• Depuy Synthes (Johnson and Johnson Services, Inc.)
• Exactech, Inc.
• JRI Orthopaedics Limited
• SAMO SpA
The List of Companies - North America Artificial Joints Market
The North America Artificial Joints Market is valued at US$ 7,234.2 Million in 2019, it is projected to reach US$ 11,440.2 Million by 2027.
As per our report North America Artificial Joints Market, the market size is valued at US$ 7,234.2 Million in 2019, projecting it to reach US$ 11,440.2 Million by 2027. This translates to a CAGR of approximately 6.0% during the forecast period.
The North America Artificial Joints Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Artificial Joints Market report:
The North America Artificial Joints Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Artificial Joints Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Artificial Joints Market value chain can benefit from the information contained in a comprehensive market report.